The FDA shortage exemption that broadly covered compounding from 20222024 has narrowed since semaglutide was removed from the shortage list
People who drink more water are less inclined to sugar or carbonated beverages
FDA Approval Criteria: For FDA approval as weight loss medication, drugs must demonstrate: Efficacy Requirements: At least 5% average weight loss greater than placebo At least 35% of patients lose 5% body weight At least 15% of patients lose 10% body weight Safety Requirements: Acceptable safety profile in clinical trials Benefits outweigh risks Appropriate for long-term use All newer GLP-1 medications far exceed the minimum efficacy requirements, which explains their dominance
Experimental research also suggests that GLP-1 signaling may impact energy expenditure, metabolic flexibility, and glucose transport mechanisms
The person who lost weight burns fewer calories at rest, during exercise, and even during sleep
Upper arm: The back of the upper arm is another option, particularly for individuals who prefer injecting in a less visible area
